Market
Will NIH reverse its policy on vaccine research under Bhattacharya by end of 2025?
3
Donald Trump•Jay Bhattacharya•National Institutes of Health•NIH•Bhattacharya•Stanford University•Nobel•Health•Human Services•Republicans•Kennedy•Libertarians•Trump
Resolution / Starting Odds
Yes • 50%
No • 50%
Official NIH policy documents or public announcements
Story
Trump's NIH Director Nominee Faces Opposition from 75 Nobel Laureates
Dec 11, 2024, 01:53 PM
President-elect Donald Trump has nominated Dr. Jay Bhattacharya to head the National Institutes of Health (NIH), aiming to address the chronic disease crisis in the U.S. Bhattacharya, a professor at Stanford University, has been described as an 'eminently qualified person' by some supporters. His appointment is viewed as a potential shift towards focusing on prevention and reversing chronic diseases. However, this nomination has sparked controversy, with over 75 Nobel laureates expressing concerns about the implications for health research and policy. Critics worry that Bhattacharya's views on vaccines and health could lead to the promotion of debunked claims linking vaccines to autism. Additionally, Robert F. Kennedy Jr. has been considered for the position of Secretary of Health and Human Services, raising further concerns among pro-life Republicans due to his pro-abortion stance. Kennedy has also been involved in a fundraising deal with Libertarians, which has provided a financial boost to his campaign and Trump's.
View original story
Similar markets
Confirmed • 25%
Withdrawn • 25%
Delayed • 25%
Rejected • 25%
No change in funding • 25%
Funding halted • 25%
Funding reduced • 25%
Increased funding • 25%
Yes • 50%
No • 50%
Low (Below 40%) • 25%
No significant data • 25%
Moderate (40-60%) • 25%
High (Above 60%) • 25%
Public health initiatives • 25%
Academic freedom • 25%
Other focus area • 25%
Research funding allocation • 25%
